Metformin (N,N-dimethylbiguanide) activity relies also on inhibition of fructose-1-6- bisphosphatase-1 (FBP1) by regulating hepatic glucose production, reducing HGF and normalizing blood glucose levels in hyperglycemic type 2 diabetics [171]. Here, FBP1 is linked to type 2 diabetes mellitus.